Abstract
Abstract : Breast cancer is one of the leading causes of cancer deaths of women in the United States. Fortunately, this disease is no longer a black box that can only be studied empirically. Recent advances in understanding of normal mammary development and carcinogenic processes have identified a number of specific genes and processes that are dysregulated in breast cancer. This means that research on breast cancer has finally advanced to the stage where a concentrated effort in translational research will yield great strides in detection, diagnosis, and treatment. The Molecular Medicine graduate training program at Yale was recently developed to address these issues. This program was developed to offer an interdisciplinary course of study that will foster an integrated view of disease, built upon a rigorous foundation of basic sciences. The emphasis on disease mechanisms and translational research is unique to Molecular Medicine, and distinguishes it from other pre-doctoral programs at Yale. The Predoctoral Training Program in Breast Cancer Research will recruit individuals interested in careers in breast cancer research to the Molecular Medicine Program, provide specialist training in breast cancer-specific areas, and integrate their training experience with scientists and clinicians investigating breast cancer at Yale.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have